Nano Coulomb Breath Analyzer

The WLD801 is a non-invasive analyzer that measures exhaled nitric oxide (FeNO) levels to assess airway inflammation in respiratory conditions such as asthma and allergic rhinitis. It provides rapid, objective diagnostic support for clinicians in pulmonology and allergy departments. The device delivers quantitative results with high sensitivity and specificity for patient management.

Portable breath analyzer for non-invasive detection and measurement of volatile organic compounds and biomarkers in exhaled breath. Applicable in respiratory diagnostics, metabolic screening, and point-of-care testing environments. Provides rapid analysis with minimal patient preparation required.

A diagnostic device for measuring nitric oxide (NO) levels in exhaled breath, available in models Reslink R100 and Reslink R200. It has a measurement range of 1-3500ppb and is a Class II medical device certified by China's NMPA. The device is used for assisting in the diagnosis and assessment of conditions such as asthma and chronic obstructive pulmonary disease, as well as for monitoring disease progression.

A high-precision nitric oxide (NO) measurement device designed for detecting NO and non-oxygen carbon dioxide in exhaled gas. The eNoglow series includes models LN1000, LN2000, LN3000, and LN4000, with a measurement range of 0-5000ppb and a resolution of 0.01ppb. It is a Class II medical device registered with China's NMPA and designed to meet the high standards required in clinical settings such as pediatrics, cardiology, and intensive care units.

Diagnostic instrument for analyzing exhaled breath gases in clinical and research settings. Utilized for hydrogen breath testing and other respiratory diagnostic procedures.

A portable exhaled carbon dioxide (CO2) measurement device using non-dispersive infrared (NDIR) technology, available in models etCOlink C100 and etCOlink C200. It has a measurement range of 0-100ppm and is a Class II medical device registered with China's NMPA. Users can perform testing activities through a human-computer interface, making it suitable for clinical applications including respiratory disease diagnosis, treatment effect evaluation, and hemoglobin monitoring.

Carbon-13 breath test analyzer for non-invasive diagnosis of gastrointestinal disorders including H. pylori infection, small intestinal bacterial overgrowth, and lactose malabsorption. The device measures exhaled carbon-13 levels to assess metabolic function and intestinal health with rapid turnaround times.

Point-of-care analyzer for blood pH, oxygen, and carbon dioxide measurement. Rapid results for respiratory assessment in critical care settings.

A wearable device that performs laboratory-level analysis of biomarkers in breath samples in near-real-time. Based on headspace gas chromatography technology, it enables on-site measurement of metabolic markers including fat combustion indicators. Developed through 15+ years of research at ETH Zurich.

A diagnostic analyzer for conducting carbon-14 urea breath tests to detect gastric bacterial infections. The device measures isotopic composition in breath samples for clinical diagnosis.

A diagnostic device designed to analyze oxygen levels and concentrations.

The NObreath® FeNO device measures fractional exhaled nitric oxide (FeNO) to assess airway inflammation and aid in asthma diagnosis and management. This non-invasive breath test conforms to BTS/NICE/SIGN, ATS, and ERS guidelines and is suitable for both adult and pediatric patients. The device includes ambient NO monitoring capability for environmental assessment.